November 5, 2020

Vetsina Animal Diagnostics appoints non-executive director

Vetsina Animal Diagnostics has announced the appointment of David Whitcombe as its non-executive director.

Whitcombe has more than 10 years of academic research and 15 years in industrial R&D. During his career, he has produced several publications and patents, including the Scorpions technology that formed the basis of his start-up business DxS Ltd in 2000.

Whitcombe was head of technology development at AstraZeneca Diagnostics for four years, leading a team focused on developing new genomic technologies.

Vetsina CEO Dr. Simon Wheeler said: "We are very pleased that David has joined the board here at Vetsina… he has a highly relevant experience and will be a great asset to the team."

The appointment follows the news of the death of Vetsina founder Hugh Ilyine.

"Hugh led DESTINA Genomics Ltd through a successful period of growth. During that time, through his relationships with academic partners at the University of Edinburgh, he nurtured his enthusiasm for animal science and had the foresight to embark on several projects in animal health using the DESTINA technology," Dr. Wheeler said.

"He was greatly respected by the academic colleagues for his intellect, insight and enthusiasm. We will miss Hugh greatly and our thoughts are with his family and former colleagues at DESTINA and beyond."

- Vetsina